Millipore Corporation Awards Flow Cytometer to Advance Cell Biology Research at Renowned Research Hospital

Mari Hashitate Dallas, MD, receives Millipore Guava flow cytometer for
innovative research on umbilical cord blood transplants.
BILLERICA, Mass.--(Business Wire)--
Millipore Corporation (NYSE: MIL), a Life Science leader providing technologies,
tools and services for bioscience research and biopharmaceutical manufacturing,
today awarded Dr. Mari Hashitate Dallas of St. Jude Children`s Research Hospital
in Memphis, Tenn., the Millipore Guava Flow Cytometry Award. This award
recognizes her innovative approach to using flow cytometry/cell analysis to
improve the outcome of umbilical cord blood transplants in pediatric patients.
Dr. Dallas will receive the recently released guava easyCyte 8HT flow cytometry
instrument to better facilitate and expedite her research.

Using this instrument will enable Dr. Dallas` lab to more efficiently monitor
the number and type of immune cells in blood samples drawn over the course of
time following umbilical cord blood transplants. From this information, the lab
will assess whether immune systems are properly reconstituting following
transplantation and then identify the factors that improve success.

"Dr. Dallas` submission was selected because it best represented an application
of multiparametric flow cytometry that will play an important role in improving
patient outcomes," said John Sweeney, Vice President Life Science Business Unit.
"Millipore is proud to support Dr. Dallas` innovative research knowing that the
flow cytometer system will help to accelerate her critical work."

The guava easyCyte 8HT is a key cell analysis tool which allows scientists to
save critical time and funds by enabling them to take control of their research
without sacrificing results when compared to those generated on traditional
instruments - all within their own lab. Traditional flow cytometers need a
full-time technician, making them expensive to operate, but guava flow
cytometers only require the individual who will run the samples. An additional
benefit of this instrument is that it can handle smaller sample volumes than
other flow cytometry instruments and process samples in a 96 well plate format.

"We process 200 to 300 samples at each time point in our studies," said Dr.
Dallas. "Until now, we had to send the samples to the core lab and try our best
to align our research with their hours. Having a Guava flow cytometer allows us
to conduct these analyses in our own lab on our own schedule," she continued.

Dr. Dallas` proposal was selected from more than 70 high-quality applications
submitted to Millipore by research labs worldwide. Proposals were assessed for
their innovative approach to using flow cytometry to address challenging
research questions and represented a wide range of applications, including stem
cell differentiation, cell signaling, therapeutic mechanisms of action, and the
molecular basis of disease.

Dr. Mari Hashitate Dallas is a member of St. Jude Children`s Research Hospital
Division of Bone Marrow Transplantation and Cellular Therapy. Her research
focuses on stem cell and T-cell development, cord blood transplants, and
infections and immune reconstitution after bone marrow transplant.

About Millipore

Millipore (NYSE: MIL) is a Life Science leader providing cutting-edge
technologies, tools, and services for bioscience research and biopharmaceutical
manufacturing. As a strategic partner, we collaborate with customers to confront
the world`s challenging human health issues. From research to development to
production, our scientific expertise and innovative solutions help customers
tackle their most complex problems and achieve their goals. Millipore
Corporation is an S&P 500 company with more than 5,900 employees worldwide. For
more information, please contact Millipore Tech Service at 1-800-548-7853 or
951-676-8080 or visit www.millipore.com.

ADVANCING LIFE SCIENCE TOGETHER TM

Research. Development. Production.

Millipore Media Contact:
Millipore Corporation
Karen Marinella Hall, 978-715-1567
Cell: 508-212-9476
Director of Corporate Communications
karen_hall@millipore.com
or
Millipore Corporate Giving Contact:
Millipore Corporation
Tara Duplaga, 978-715-1268
Corporate Giving Representative
tara_duplaga@millipore.com

Copyright Business Wire 2009